MLN64 induces mitochondrial dysfunction associated with increased mitochondrial cholesterol content

Redox Biology

Volumn 12, Issue , 2017, Pages 274-284

  Balboa, Elisa ^a   Castro, Juan ^a   Pinochet, María José ^a   Cancino, Gonzalo I ^b,f   Matías, Nuria ^c   José Sáez, Pablo ^d   Martínez, Alexis ^b   Álvarez, Alejandra R ^b   Garcia Ruiz, Carmen ^c,e   Fernandez Checa, José C ^c,e   Zanlungo, Silvana ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d INSTITUT CURIE   (France)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSIDAD MAYOR   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUTATHIONE; MEMBRANE PROTEIN; PROTEIN MLN64; SUPEROXIDE; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHOLESTEROL; STARD3 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; ENDOSOME; HOMEOSTASIS; HUMAN; HUMAN CELL; LIVER CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR IMAGING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ADMINISTRATION AND DOSAGE; ANIMAL; CHO CELL LINE; CRICETULUS; CYTOLOGY; DEPENDOPARVOVIRUS; GENE VECTOR; GENETICS; HEP-G2 CELL LINE; LIVER; METABOLISM; MITOCHONDRION; NIEMANN PICK DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CARRIER PROTEINS; CHO CELLS; CHOLESTEROL; CRICETULUS; DEPENDOVIRUS; GENETIC VECTORS; GLUTATHIONE; HEP G2 CELLS; HUMANS; LIVER; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE PROTEINS; MICE; MITOCHONDRIA; NIEMANN-PICK DISEASES; SUPEROXIDES;

EID: 85014679058     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2017.02.024     Document Type: Article

References (48)

1. [1] Soccio, R.E., Breslow, J.L., StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J. Biol. Chem. 278 (2003), 22183–22186.
2. [2] Watari, H., Arakane, F., Moog-Lutz, C., Kallen, C.B., Tomasetto, C., Gerton, G.L., Rio, M.C., Baker, M.E., Strauss, J.F. 3rd, MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc. Natl. Acad. Sci. USA 94 (1997), 8462–8467.
3. [3] Alpy, F., Stoeckel, M.E., Dierich, A., Escola, J.M., Wendling, C., Chenard, M.P., Vanier, M.T., Gruenberg, J., Tomasetto, C., Rio, M.C., The steroidogenic acute regulatory protein homolog MLN64, a late endosomal cholesterol-binding protein. J. Biol. Chem. 276 (2001), 4261–4269.
4. [4] Alpy, F., Wendling, C., Rio, M.C., Tomasetto, C., MENTHO, a MLN64 homologue devoid of the START domain. J. Biol. Chem. 277 (2002), 50780–50787.
5. [5] Alpy, F., Tomasetto, C., MLN64 and MENTHO, two mediators of endosomal cholesterol transport. Biochem Soc. Trans. 34 (2006), 343–345.
6. [6] Zhang, M., Liu, P., Dwyer, N.K., Christenson, L.K., Fujimoto, T., Martinez, F., Comly, M., Hanover, J.A., Blanchette-Mackie, E.J., Strauss, J.F. 3rd, MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J. Biol. Chem. 277 (2002), 33300–33310.
7. [7] Kishida, T., Kostetskii, I., Zhang, Z., Martinez, F., Liu, P., Walkley, S.U., Dwyer, N.K., Blanchette-Mackie, E.J., Radice, G.L., Strauss, J.F. 3rd, Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism. J. Biol. Chem. 279 (2004), 19276–19285.
8. [8] Stocco, D.M., StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev. Physiol. 63 (2001), 193–213.
9. [9] Sugawara, T., Holt, J.A., Driscoll, D., Strauss, J.F. 3rd, Lin, D., Miller, W.L., Patterson, D., Clancy, K.P., Hart, I.M., Clark, B.J., et al. Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc. Natl. Acad. Sci. USA 92 (1995), 4778–4782.
10. [10] Charman, M., Kennedy, B.E., Osborne, N., Karten, B., MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein. J. Lipid Res 51 (2010), 1023–1034.
11. [11] Patterson, M.C., Hendriksz, C.J., Walterfang, M., Sedel, F., Vanier, M.T., Wijburg, F., Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol. Genet Metab. 106 (2012), 330–344.
12. [12] Carstea, E.D., Morris, J.A., Coleman, K.G., Loftus, S.K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M.A., Pavan, W.J., Krizman, D.B., Nagle, J., Polymeropoulos, M.H., Sturley, S.L., Ioannou, Y.A., Higgins, M.E., Comly, M., Cooney, A., Brown, A., Kaneski, C.R., Blanchette-Mackie, E.J., Dwyer, N.K., Neufeld, E.B., Chang, T.Y., Liscum, L., Strauss, J.F. 3rd, Ohno, K., Zeigler, M., Carmi, R., Sokol, J., Markie, D., O'Neill, R.R., van Diggelen, O.P., Elleder, M., Patterson, M.C., Brady, R.O., Vanier, M.T., Pentchev, P.G., Tagle, D.A., Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277 (1997), 228–231.
13. [13] van der Kant, R., Zondervan, I., Janssen, L., Neefjes, J., Cholesterol binding molecules MLN64 and ORP1L mark distinct late endosomes with transporters ABCA3 and NPC1. J. Lipid Res., 2013.
14. [14] Ha, S.D., Park, S., Han, C.Y., Nguyen, M.L., Kim, S.O., Cellular adaptation to anthrax lethal toxin-induced mitochondrial cholesterol enrichment, hyperpolarization, and reactive oxygen species generation through downregulating MLN64 in macrophages. Mol. Cell Biol. 32 (2012), 4846–4860.
15. [15] Colell, A., Garcia-Ruiz, C., Lluis, J.M., Coll, O., Mari, M., Fernandez-Checa, J.C., Cholesterol impairs the adenine nucleotide translocator-mediated mitochondrial permeability transition through altered membrane fluidity. J. Biol. Chem. 278 (2003), 33928–33935.
16. [16] Yu, W., Gong, J.S., Ko, M., Garver, W.S., Yanagisawa, K., Michikawa, M., Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J. Biol. Chem. 280 (2005), 11731–11739.
17. [17] Echegoyen, S., Oliva, E.B., Sepulveda, J., Diaz-Zagoya, J.C., Espinosa-Garcia, M.T., Pardo, J.P., Martinez, F., Cholesterol increase in mitochondria: its effect on inner-membrane functions, submitochondrial localization and ultrastructural morphology. Biochem. J. 289:Pt 3 (1993), 703–708.
18. [18] Mari, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., Enrich, C., Fernandez-Checa, J.C., Garcia-Ruiz, C., Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 4 (2006), 185–198.
19. [19] Garcia-Ruiz, C., Mari, M., Colell, A., Morales, A., Caballero, F., Montero, J., Terrones, O., Basanez, G., Fernandez-Checa, J.C., Mitochondrial cholesterol in health and disease. Histol. Histopathol. 24 (2009), 117–132.
20. [20] Tichauer, J.E., Morales, M.G., Amigo, L., Galdames, L., Klein, A., Quinones, V., Ferrada, C., Alvarez, A.R., Rio, M.C., Miquel, J.F., Rigotti, A., Zanlungo, S., Overexpression of the cholesterol-binding protein MLN64 induces liver damage in the mouse. World J. Gastroenterol. 13 (2007), 3071–3079.
21. [21] He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., Vogelstein, B., A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95 (1998), 2509–2514.
22. [22] Kozarsky, K.F., Jooss, K., Donahee, M., Strauss, J.F. 3rd, Wilson, J.M., Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat. Genet. 13 (1996), 54–62.
23. [23] Pfaffl, M.W., Horgan, G.W., Dempfle, L., Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucl. Acids Res., 30, 2002, e36.
24. [24] Duncan, I.W., Culbreth, P.H., Burtis, C.A., Determination of free, total, and esterified cholesterol by high-performance liquid chromatography. J. Chromatogr. 162 (1979), 281–292.
25. [25] Lluis, J.M., Colell, A., Garcia-Ruiz, C., Kaplowitz, N., Fernandez-Checa, J.C., Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology 124 (2003), 708–724.
26. [26] Sumner, J.B., A method for the colorimetric determination of phosphorus. Science 100 (1944), 413–414.
27. [27] Fernandez-Checa, J.C., Redox regulation and signaling lipids in mitochondrial apoptosis. Biochem. Biophys. Res. Commun. 304 (2003), 471–479.
28. [28] Kennedy, B.E., Madreiter, C.T., Vishnu, N., Malli, R., Graier, W.F., Karten, B., Adaptations of energy metabolism associated with increased levels of mitochondrial cholesterol in Niemann-Pick type C1-deficient cells. J. Biol. Chem. 289 (2014), 16278–16289.
29. [29] Liao, G., Yao, Y., Liu, J., Yu, Z., Cheung, S., Xie, A., Liang, X., Bi, X., Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain. Am. J. Pathol. 171 (2007), 962–975.
30. [30] Ballabio, A., Gieselmann, V., Lysosomal disorders: from storage to cellular damage. Biochim Biophys. Acta 1793 (2009), 684–696.
31. [31] Ballabio, A., Disease pathogenesis explained by basic science: lysosomal storage diseases as autophagocytic disorders. Int J. Clin. Pharm. Ther. 47:Suppl 1 (2009), S34–S38.
32. [32] Torres, S., Matias, N., Baulies, A., Nunez, S., Alarcon-Vila, C., Martinez, L., Nuno, N., Fernandez, A., Caballeria, J., Levade, T., Gonzalez-Franquesa, A., Garcia-Roves, P., Balboa, E., Zanlungo, S., Fabrias, G., Casas, J., Enrich, C., Garcia-Ruiz, C., Fernandez-Checa, J.C., Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease. Redox Biol. 11 (2016), 60–72.
33. [33] Reunert, J., Fobker, M., Kannenberg, F., Du Chesne, I., Plate, M., Wellhausen, J., Rust, S., Marquardt, T., Rapid diagnosis of 83 patients with Niemann Pick type C disease and related cholesterol transport disorders by Cholestantriol screening. EBioMedicine 4 (2016), 170–175.
34. [34] Ribas, V., Garcia-Ruiz, C., Fernandez-Checa, J.C., Mitochondria, cholesterol and cancer cell metabolism. Clin. Transl. Med., 5, 2016, 22.
35. [35] Gocze, P.M., Freeman, D.A., Plasma membrane cholesterol is utilized as steroidogenic substrate in Y-1 mouse adrenal tumor cells and normal sheep adrenal cells. Exp. Cell Res 209 (1993), 21–25.
36. [36] Freeman, D.A., Romero, A., Choi, Y.S., Plasma membrane steroidogenic cholesterol: the relative importance of membrane internalization rate and cholesterol extraction rate of internalized membrane. Endocr. Res. 24 (1998), 619–622.
37. [37] Lange, Y., Steck, T.L., Ye, J., Lanier, M.H., Molugu, V., Ory, D., Regulation of fibroblast mitochondrial 27-hydroxycholesterol production by active plasma membrane cholesterol. J. Lipid Res 50 (2009), 1881–1888.
38. [38] van der Kant, R., Zondervan, I., Janssen, L., Neefjes, J., Cholesterol-binding molecules MLN64 and ORP1L mark distinct late endosomes with transporters ABCA3 and NPC1. J. Lipid Res. 54 (2013), 2153–2165.
39. [39] Ren, S., Hylemon, P., Marques, D., Hall, E., Redford, K., Gil, G., Pandak, W.M., Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis. J. Lipid Res. 45 (2004), 2123–2131.
40. [40] Strauss, J.F. 3rd, Kishida, T., Christenson, L.K., Fujimoto, T., Hiroi, H., START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol. Cell Endocrinol. 202 (2003), 59–65.
41. [41] Bose, H.S., Baldwin, M.A., Miller, W.L., Evidence that StAR and MLN64 act on the outer mitochondrial membrane as molten globules. Endocr. Res 26 (2000), 629–637.
42. [42] Ahmad, T., Aggarwal, K., Pattnaik, B., Mukherjee, S., Sethi, T., Tiwari, B.K., Kumar, M., Micheal, A., Mabalirajan, U., Ghosh, B., Sinha Roy, S., Agrawal, A., Computational classification of mitochondrial shapes reflects stress and redox state. Cell Death Dis., 4, 2013, e461.
43. [43] Pich, S., Bach, D., Briones, P., Liesa, M., Camps, M., Testar, X., Palacin, M., Zorzano, A., The Charcot-Marie-tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet 14 (2005), 1405–1415.
44. [44] Pang, W., Zhang, Y., Zhao, N., Darwiche, S.S., Fu, X., Xiang, W., Low expression of Mfn2 is associated with mitochondrial damage and apoptosis in the placental villi of early unexplained miscarriage. Placenta 34 (2013), 613–618.
45. [45] Phillips, M.J., Voeltz, G.K., Structure and function of ER membrane contact sites with other organelles. Nat. Rev. Mol. Cell Biol. 17 (2016), 69–82.
46. [46] de Brito, O.M., Scorrano, L., Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456 (2008), 605–610.
47. [47] Wos, M., Szczepanowska, J., Pikula, S., Tylki-Szymanska, A., Zablocki, K., Bandorowicz-Pikula, J., Mitochondrial dysfunction in fibroblasts derived from patients with Niemann-Pick type C disease. Arch. Biochem. Biophys. 593 (2016), 50–59.
48. [48] Bi, X., Liao, G., Autophagic-lysosomal dysfunction and neurodegeneration in Niemann-Pick Type C mice: lipid starvation or indigestion?. Autophagy 3 (2007), 646–648.